Seed Health

Aggi is a digital health platform focused on gut health management, utilizing artificial intelligence and data analytics to assist users in understanding and improving their digestive health. The platform offers tools that enable users to track their diet, symptoms, and stool characteristics, making the process straightforward and personalized. By leveraging deep learning algorithms and computer vision, Auggi objectively analyzes stool images and provides insights into patterns and connections between dietary triggers and symptoms. This empowers users with actionable recommendations, allowing them to effectively manage chronic gut symptoms and enhance their overall well-being.

LUCA Biologics is a biotechnology company developing a new class of living medicines targeting the vaginal microbiome to impact reproductive and urogenital health. Emerging from the lab of Dr. Jacques Ravel, Primary Investigator on the vaginal microbiome division of the NIH's Human Microbiome Project, our platform takes a metagenomic and metatranscriptomic approach to the identification, screening and validation of strains with therapeutic potential. Our pipeline includes therapeutics for urinary tract infection (UTI), preterm birth (PTB), bacterial vaginosis (BV), and infertility. LUCA Biologics is a Seed Health foundry company.